Bachrodt Amy

Maze Therapeutics, Inc. · SVP

Bachrodt Amy is listed in filings as SVP at Maze Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including sale activity. Recent filings connect the profile to Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Sep 24, 2025 to Apr 2, 2026. Reported amounts are shown as $64.5K to $9.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Maze Therapeutics, Inc.MAZE$187k4.1k sharesSellFeb 2, 2026$46.03$27.17
Maze Therapeutics, Inc.MAZE$34k736 sharesSellFeb 2, 2026$46.63$27.17
Maze Therapeutics, Inc.MAZE$8.8k200 sharesSellFeb 2, 2026$44.15$27.17
Maze Therapeutics, Inc.MAZE$228k5k sharesSellJan 22, 2026$45.52$27.17
Maze Therapeutics, Inc.MAZE$103k2.6k sharesSellJan 2, 2026$39.57$27.17
Maze Therapeutics, Inc.MAZE$93k2.4k sharesSellJan 2, 2026$38.70$27.17
Maze Therapeutics, Inc.MAZE$200k5k sharesSellDec 30, 2025$40.08$27.17
Maze Therapeutics, Inc.MAZE$381k9.4k sharesSellDec 29, 2025$40.54$27.17
Maze Therapeutics, Inc.MAZE$25k600 sharesSellDec 29, 2025$41.16$27.17